Patents by Inventor Christopher David Hammerbeck

Christopher David Hammerbeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES
    Publication number: 20230408517
    Abstract: Anti-SARS-CoV-specific monoclonal antibodies, methods of making and characterizing those antibodies, and methods of using those antibodies are described herein. In some embodiments, the antibodies may bind to both SARS-CoV-1 and SARS-CoV-2. In some embodiments, the antibodies bind to S1 of the spike protein of SARS-CoV-2 including, for example, to the receptor binding domain (RBD) of S1. In some embodiments, the antibodies may block the binding of SARS-CoV-1 and/or SARS-CoV-2 to ACE-2. Such antibodies are useful as diagnostic and therapeutic agents.
    Type: Application
    Filed: November 24, 2021
    Publication date: December 21, 2023
    Inventors: Christine Andrea Goetz, Jody Bonnevier, Christopher David Hammerbeck, Ernesto Rubin Resnik, Cyrus B. Munshi, Enqing Tan